Titan Medical Completes Preclinical Good Laboratory Practice Procedures With Its Single-Port Robotic Surgical System

TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that all procedures under Good Laboratory Practice (“GLP”) principles associated with the acute and chronic animal studies and human … [Read more…]

Pear Therapeutics Announces FDA Submission for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression

More than 30 million U.S. adults have chronic insomnia, at significant cost to the U.S. healthcare system Cognitive Behavioral Therapy for insomnia (CBTi) is the guideline recommended first-line treatment for people with chronic insomnia The investigational product is a prescription digital therapeutic (PDT) that offers CBTi and a sleep restriction algorithm The pending submission is … [Read more…]

Elanco Finalizes Acquisition of Aratana Therapeutics

GREENFIELD, Ind.–(BUSINESS WIRE)–Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant®. This transaction allows Elanco to capture the full value of growing product Galliprant®, … [Read more…]

Halo Labs Announces Inclusion in the OTC Markets Cannabis Index Under the Ticker Symbol OTCQX: .OTCQXMJ

Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce its inclusion in the OTC Markets Cannabis Index (the “Index”) which trades on the OTCQX Market under the ticker symbol .OTCQXMJ. The Index’s … [Read more…]

NationsHearing Adds Over-the-Counter Benefit Management Services to its Offering and is Rebranding as NationsBenefitsTM

Health plans now have the option of selecting one company for multiple supplemental benefits to attract and retain Medicare Advantage enrollees FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#healthcare–NationsHearing, LLC., a leader in the hearing healthcare industry, today announces it has expanded its offering to include over-the-counter (OTC) benefit management services and as a result, is now known as … [Read more…]

Neurogene Initiates Natural History Study of Charcot-Marie Tooth Disease (CMT4J)

Key data now being collected to support endpoint assessment for future gene therapy clinical trial NEW YORK–(BUSINESS WIRE)–Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced that it has enrolled the first patient in a natural history study of Charcot-Marie Tooth … [Read more…]

Clovis Oncology to Announce Second Quarter 2019 Financial Results and Host Webcast Conference Call on August 1

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2019 financial results on Thursday, August 1, 2019, before the open of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the company’s results in greater detail. The conference call … [Read more…]

Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity – two common nerve agents

DENVER–(BUSINESS WIRE)–Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development and commercialization of novel FDA-compliant cannabinoid pharmaceuticals and related drug delivery systems, today announced that it was granted Patent No. 238946 for “Use of Cannabinoids and Terpenes for Treatment of Organophosphate and Carbamate Toxicity” by the … [Read more…]

Into the Future of Healthcare: Infiniti Research Reveals Four Factors That Will Drive Change in Healthcare

LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–A well-known market intelligence company, Infiniti Research, has announced the completion of their recent article on factors shaping the future of healthcare. In this article, experts at Infiniti Research unveil four factors that would play a key role in shaping the future of healthcare. Over the past couple of years, the healthcare industry has … [Read more…]

Influenza A Virus, H5N1 Subtype Infections Pipeline Report, H1 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Influenza A Virus, H5N1 Subtype Infections – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Influenza A Virus, H5N1 Subtype Infections – Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Influenza A Virus, H5N1 Subtype Infections (Infectious Disease), complete with analysis by stage of … [Read more…]